Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 24th December 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect recall alert
The VMD has issued a product defect recall alert for Synulox Lactating Cow Intramammary Suspension.

Recall for Synulox Lactating Cow Intramammary Suspension

The Veterinary Medicines Directorate (VMD has issued a product defect recall alert for Synulox Lactating Cow Intramammary Suspension, manufactured by Zoetis UK.

A statement reads: “Following a recent Good Manufacturing Practice (GMP) inspection of one of the active pharmaceutical ingredient (API) manufacturers for Synulox LC, a statement of non-compliance with GMP has been issued.

“As a precaution, batches of this product containing API that is impacted by this non-compliance statement are being recalled from the market with immediate effect to the end-user (farm) level."

Zoetis UK Ltd is contacting veterinary surgeons and wholesaler dealers to examine inventory and quarantine products subject to this recall.

This issue impacts the following batches that have been placed on the UK market: 

91939702 Synulox LC x 12 syringes 31/01/2021
81950600 Synulox LC x 24 syringes 30/04/2020
81958301 Synulox LC x 24 syringes 30/04/2020
81962601 Synulox LC x 24 syringes 31/05/2020
81966700 Synulox LC x 24 syringes 30/06/2020
81968102 Synulox LC x 24 syringes 30/06/2020
81968300 Synulox LC x 24 syringes 30/06/2020
91927402 Synulox LC x 24 syringes 30/11/2020
91938601 Synulox LC x 24 syringes 31/01/2021
91938700 Synulox LC x 24 syringes 31/01/2021
91954001 Synulox LC x 24 syringes 31/03/2021

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.